within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AE02_Lepirudin;

model Lepirudin
  extends Pharmacolibrary.Drugs.ATC.B.B01AE02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>B01AE02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Lepirudin is a recombinant hirudin derived from yeast cells and is a direct thrombin inhibitor. It was used as an anticoagulant in patients with heparin-induced thrombocytopenia (HIT). Due to risk of serious bleeding and the availability of alternative agents, lepirudin was withdrawn from the market and is no longer approved for use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters as observed in adult patients with heparin-induced thrombocytopenia, following intravenous administration.</p><h4>References</h4><ol><li><p>Meiring, SM, et al., &amp; Kotzé, HF (1999). Sites of elimination and pharmacokinetics of recombinant [131I]lepirudin in baboons. <i>Journal of pharmaceutical sciences</i> 88(5) 523–529. DOI:<a href=\"https://doi.org/10.1021/js980407q\">10.1021/js980407q</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10229643/\">https://pubmed.ncbi.nlm.nih.gov/10229643</a></p></li><li><p>Fries, D (2011). Thrombosis prophylaxis in critically ill patients. <i>Wiener medizinische Wochenschrift (1946)</i> 161(3-4) 68–72. DOI:<a href=\"https://doi.org/10.1007/s10354-011-0878-6\">10.1007/s10354-011-0878-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21404142/\">https://pubmed.ncbi.nlm.nih.gov/21404142</a></p></li><li><p>Baetz, BE, &amp; Spinler, SA (2008). Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases. <i>Pharmacotherapy</i> 28(11) 1354–1373. DOI:<a href=\"https://doi.org/10.1592/phco.28.11.1354\">10.1592/phco.28.11.1354</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18956996/\">https://pubmed.ncbi.nlm.nih.gov/18956996</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Lepirudin;
